Matthew B. Klein - Net Worth and Insider Trading
Matthew B. Klein Net Worth
The estimated net worth of Matthew B. Klein is at least $10 Million dollars as of 2024-12-01. Matthew B. Klein is the CHIEF EXECUTIVE OFFICER of PTC Therapeutics Inc and owns about 225,807 shares of PTC Therapeutics Inc (PTCT) stock worth over $10 Million. Details can be seen in Matthew B. Klein's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Matthew B. Klein has not made any transactions after 2024-04-19 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Matthew B. Klein
Matthew B. Klein Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Matthew B. Klein owns 2 companies in total, including PTC Therapeutics Inc (PTCT) , and ClearPoint Neuro Inc (CLPT) .
Click here to see the complete history of Matthew B. Klein’s form 4 insider trades.
Insider Ownership Summary of Matthew B. Klein
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| PTCT | PTC Therapeutics Inc | 2024-04-19 | Chief Development Officer |
| CLPT | ClearPoint Neuro Inc | 2020-04-16 | director |
Matthew B. Klein Latest Holdings Summary
Matthew B. Klein currently owns a total of 1 stock. Matthew B. Klein owns 225,807 shares of PTC Therapeutics Inc (PTCT) as of April 19, 2024, with a value of $10 Million.
Latest Holdings of Matthew B. Klein
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| PTCT | PTC Therapeutics Inc | 2024-04-19 | 225,807 | 43.88 | 9,908,411 |
Holding Weightings of Matthew B. Klein
Matthew B. Klein Form 4 Trading Tracker
According to the SEC Form 4 filings, Matthew B. Klein has made a total of 12 transactions in PTC Therapeutics Inc (PTCT) over the past 5 years, including 0 buys and 12 sells. The most-recent trade in PTC Therapeutics Inc is the sale of 3,361 shares on April 19, 2024, which brought Matthew B. Klein around $83,655.
Insider Trading History of Matthew B. Klein
- 1
Matthew B. Klein Trading Performance
Matthew B. Klein Ownership Network
Matthew B. Klein Owned Company Details
What does PTC Therapeutics Inc do?
Who are the key executives at PTC Therapeutics Inc?
Matthew B. Klein is the Chief Development Officer of PTC Therapeutics Inc. Other key executives at PTC Therapeutics Inc include CHIEF FINANCIAL OFFICER Pierre Gravier , Chief Medical Officer Lee Scott Golden , and Chief Business Officer Eric Pauwels .
PTC Therapeutics Inc (PTCT) Insider Trades Summary
Over the past 18 months, Matthew B. Klein made 4 insider transaction in PTC Therapeutics Inc (PTCT) with a net sale of 22,455. Other recent insider transactions involving PTC Therapeutics Inc (PTCT) include a net sale of 4,787 shares made by Eric Pauwels , a net sale of 2,701 shares made by Lee Scott Golden , and a net purchase of 5,431 shares made by Pierre Gravier .
In summary, during the past 3 months, insiders sold 0 shares of PTC Therapeutics Inc (PTCT) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 87,282 shares of PTC Therapeutics Inc (PTCT) were sold and 7,700 shares were bought by its insiders, resulting in a net sale of 79,582 shares.
PTC Therapeutics Inc (PTCT)'s detailed insider trading history can be found in Insider Trading Tracker table.
PTC Therapeutics Inc Insider Transactions
Matthew B. Klein Mailing Address
Above is the net worth, insider trading, and ownership report for Matthew B. Klein. You might contact Matthew B. Klein via mailing address: C/o Ptc Therapeutics, Inc., 100 Corporate Court, South Plainfield Nj 07080.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
